Iovance Biotherapeutics (NasdaqGM:IOVA) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Company ParticipantsAndrew Tsai - Managing DirectorBrian Gastman - EVP of Transitional Medicine and ResearchCorleen Roche - CFODan Kirby - Chief Commercial OfficerDavid Dai - DirectorFrederick Vogt - Interim CEO and PresidentIgor Bilinsky - COOReni Benjamin - Managing DirectorSara Pellegrino - SVP of Investor Relations and Corporate CommunicationsNone - Company RepresentativeConference Call ParticipantsAsthika Goonew ...

Repligen (NasdaqGS:RGEN) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Company ParticipantsBrandon Couillard - Managing DirectorCasey Woodring - Vice President Equity ResearchDoug Schenkel - Managing Director, Life Science Tools, and DiagnosticsJacob Johnson - VP and Head of Investor RelationsJason Garland - CFOOlivier Loeillot - President and CEOPhilip Boyd - Senior Managing DirectorSubbu Nambi - Managing Director and Healthcare Equity ResearchNone - Company RepresentativeConference Call Participants ...

American Tower (NYSE:AMT) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Company ParticipantsBatya Levi - Managing DirectorMichael Rollins - Managing DirectorNick Del Deo - Managing DirectorRichard Choe - Vice President of Equity ResearchRodney Smith - EVP, CFO, and TreasurerSpencer Kurn - SVP of Investor RelationsSteven Vondran - President and CEOConference Call ParticipantsBrandon Nispel - Director and Equity Research AnalystBrendan Lynch - Vice President and Equity Research AnalystDavid Barden - Res ...

Ambac Financial Group (NYSE:AMBC) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Company ParticipantsClaude LeBlanc - President and CEODavid Trick - EVP, CFO and TreasurerKaren Beyer - Head of Investor RelationsConference Call ParticipantsMark Hughes - Managing Director and Senior Equity Research AnalystOperatorAs a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Karen Beyer, Head of Investor Relations. Please go ahead.Karen BeyerThank you. Good morning, welco ...

American Tower (NYSE:AMT) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Company ParticipantsBatya Levi - Managing DirectorMichael Rollins - Managing DirectorNick Del Deo - Managing DirectorRichard Choe - Vice President of Equity ResearchRodney Smith - EVP, CFO, and TreasurerSpencer Kurn - SVP of Investor RelationsSteven Vondran - President and CEOConference Call ParticipantsBrandon Nispel - Director and Equity Research AnalystBrendan Lynch - Vice President and Equity Research AnalystDavid Barden - Res ...

CECO Environmental (NasdaqGS:CECO) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Company ParticipantsAmit Dayal - Managing DirectorMarcio Pinto - Head of Financial Planning and Investor RelationsPeter Johansson - Chief Financial and Strategy OfficerTodd Gleason - CEOConference Call ParticipantsAaron Spychalla - Senior Research AnalystBobby Brooks - Senior Research AnalystGerard Sweeney - Managing Director and Senior Research AnalystJim Ricchiuti - Senior AnalystRob Brown - Senior Research AnalystOpera ...

Orthofix Medical (NasdaqGS:OFIX) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Company ParticipantsJulie Andrews - CFOJulie Dewey - Chief Investor Relations and Communications OfficerMassimo Calafiore - President and CEOMathew Blackman - Managing DirectorMichaela Smith - Equity Research AssociateTom Stephan - AVPConference Call ParticipantsMike Petusky - Managing Director and Senior Research AnalystOperatorThank you. I would now like to turn the call over to Julie Dewey.Julie DeweyThank you, operator, ...

Xometry (NasdaqGS:XMTR) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Company ParticipantsBrian Drab - Partner and Co-Group Head of IndustrialsEric Sheridan - Partner and Managing DirectorJames Miln - CFOMatthew Swanson - Director, Equity ResearchRandy Altschuler - CEOSanjeev Singh Sahni - PresidentShawn Milne - VP of Investor RelationsConference Call ParticipantsAndrew Boone - Managing Director and Equity Research AnalystCory Carpenter - Executive Director and Senior Equity Research Analyst, Internet ...

Kiniksa Pharmaceuticals International (NasdaqGS:KNSA) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Company ParticipantsGeoff Meacham - Managing DirectorJohn Paolini - Chief Medical OfficerJonathan Kirshenbaum - Senior Manager of Investor RelationsJoyce Chang - Managing DirectorMark Ragosa - CFONick Lorusso - VP of Biotech Equity ResearchRoss Moat - COOSanj Patel - CEO and Chairman of the BoardConference Call ParticipantsEva Fortea - Executive Director and Senior Biotechnology AnalystRoger Song - Seni ...

Iovance Biotherapeutics (NasdaqGM:IOVA) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Company ParticipantsAndrew Tsai - Managing DirectorBrian Gastman - EVP of Transitional Medicine and ResearchCorleen Roche - CFODan Kirby - Chief Commercial OfficerDavid Dai - DirectorFrederick Vogt - Interim CEO and PresidentFriedrich Finckenstein - Chief Medical OfficerIgor Bilinsky - COOReni Benjamin - Managing DirectorSara Pellegrino - SVP of Investor Relations and Corporate CommunicationsNone - Company Representa ...